Cargando…
APOBEC3G mRNA expression in exposed seronegative and early stage HIV infected individuals decreases with removal of exposure and with disease progression
BACKGROUND: APOBEC3G is an antiretroviral factor that acts by inducing G to A mutations. In this study, we examined the expression of APOBEC3G in uninfected HIV-1 exposed individuals at the time of their partner's diagnosis and one year later. We then compared this expression with that of infec...
Autores principales: | Vázquez-Pérez, Joel A, Ormsby, Christopher E, Hernández-Juan, Ramón, Torres, Klintsy J, Reyes-Terán, Gustavo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2661038/ https://www.ncbi.nlm.nih.gov/pubmed/19254362 http://dx.doi.org/10.1186/1742-4690-6-23 |
Ejemplares similares
-
Expression Analysis of LEDGF/p75, APOBEC3G, TRIM5alpha, and Tetherin in a Senegalese Cohort of HIV-1-Exposed Seronegative Individuals
por: Mous, Kim, et al.
Publicado: (2012) -
Influence of quinacrine and chloroquine on the in vitro 3′-azido-3′-deoxythymidine antiretroviral effect
por: Torres, Klintsy J, et al.
Publicado: (2015) -
Cellular Immune Responses to SARS-CoV-2 in Exposed Seronegative Individuals
por: Norton, Natasha J., et al.
Publicado: (2023) -
Human Retroviral Host Restriction Factors APOBEC3G and APOBEC3F Localize to mRNA Processing Bodies
por: Wichroski, Michael J, et al.
Publicado: (2006) -
The Roles of APOBEC3G Complexes in the Incorporation of APOBEC3G into HIV-1
por: Ma, Jing, et al.
Publicado: (2013)